Contact this trialFirst, we need to learn more about you.
Cytokine
Anti-PD-1 + Aldesleukin for Melanoma and Kidney Cancer
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is studying the combination of pembrolizumab and aldesleukin to see how well it works compared to pembrolizumab alone in treating participants with metastatic or advanced melanoma or renal cell carcinoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service